The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2024

Filed:

Apr. 12, 2021
Applicant:

Northwestern University, Evanston, IL (US);

Inventors:

Samuel I. Stupp, Chicago, IL (US);

Mark Trosper McClendon, Chicago, IL (US);

Guifa Xi, Chicago, IL (US);

Bo Timmy Bjoern Fyrner, Kopparberg, SE;

Cara S. Smith, Chicago, IL (US);

Nicholas A. Sather, Evanston, IL (US);

Assignee:

Northwestern University, Evanston, IL (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 45/06 (2006.01); A61K 47/54 (2017.01); A61K 47/61 (2017.01); A61K 47/64 (2017.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1875 (2013.01); A61K 45/06 (2013.01); A61K 47/549 (2017.08); A61K 47/61 (2017.08); A61K 47/641 (2017.08); A61K 47/645 (2017.08); A61P 35/00 (2018.01);
Abstract

Provided herein are compositions comprising peptide amphiphiles, glycosylated peptide amphiphiles (GPAs), supramolecular nanostructures assembled therefrom, and methods of use thereof. The peptide amphiphiles described herein may extend the half-life of bone morphogenic proteins, promote cell differentiation, suppress proliferation, and increase chemosensitivity of cells. Accordingly, the compositions described herein may be used for cancer treatment methods. In particular, provided herein are bone morphogenic proteins bound to peptide amphiphiles and glycosylated peptide amphiphiles or composites thereof, and methods of use of the same for the treatment of cancer. Also, provided herein are bone morphogenic proteins bound to peptide amphiphiles and glycosylated peptide amphiphiles or composites thereof, and methods of use of the same in a combinatorial approach together with chemotherapeutic medications for the treatment of cancer.


Find Patent Forward Citations

Loading…